David Pendarvis - Nov 11, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administrative Officer
Signature
David Pendarvis, Chief Administrative Officer
Stock symbol
RMD
Transactions as of
Nov 11, 2021
Transactions value $
-$302,007
Form type
4
Date filed
11/15/2021, 01:06 PM
Previous filing
Nov 5, 2021
Next filing
Nov 18, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability -$402K -1.55K -1.28% $259.47 120K Nov 11, 2021 Direct F1
transaction RMD ResMed Common Stock Options Exercise $99.9K +983 +0.82% $101.64 120K Nov 11, 2021 Direct
transaction RMD ResMed Common Stock Gift $0 -10K -8.3% $0.00 110K Nov 11, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -983 -5.05% $0.00 18.5K Nov 11, 2021 ResMed Common Stock 983 $101.64 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/14/2018, 11/21/2019 and 11/19/2020.
F2 Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization. Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares.
F3 Includes 64.3996 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.
F4 Represents date options first became exercisable. Options vest 1/3 per year.